In terms of inflammation, according to our summary and current research results, we have only observed the relationship between PHLPP2 and inflammation-related pathways in other cancers, and there is no relevant evidence in LC, and the immune-related lung damage caused by smoking is relatively extensive, so this aspect can also be explored as a future research direction. Here, PHLPP2 is linked to cancer.